SecBot SecBot
DEFA14A ·Filed Apr 24, 2026

IMNM

Immunome Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001140361-26-016689
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine proxy filing with no material changes. Monitor for any unexpected developments in the actual proxy materials, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$23.49
T+0 close · Apr 24, 2026 · via day close
Latest settled
−2.60%
T+60 · $22.88
Vs SPY
−7.37%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 27 $23.49entry
  2. T+1 · 7mo ago +0.94%α +1.42% · $23.71
  3. T+5 · 7mo ago −0.68%α −1.08% · $23.33
  4. T+20 · 6mo ago −6.73%α −11.68% · $21.91
  5. T+60 · 4mo ago −2.60%α −7.37% · $22.88
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Immunome Inc. filed a definitive proxy statement (DEFA14A) for an upcoming shareholder meeting, which includes routine matters such as director elections and executive compensation. The filing is standard and does not contain any activist demands, merger proposals, or unexpected corporate actions. Market data shows recent insider selling activity, but no significant changes in analyst sentiment.

Key Financial Metrics

Vote
director election

Key Facts

  • Routine proxy filing for shareholder meeting
  • No activist campaign or merger proposal
  • Standard agenda items: director elections and executive compensation
  • Recent insider selling of $1.6M vs $501K in buys
  • 95% bullish analyst sentiment with 19 buy ratings

Financial Impact

No immediate financial impact

revenueepsdilution

Risk Factors

  • Potential for unexpected developments in full proxy materials
  • Insider selling could indicate lack of confidence

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001140361-26-016689
Document: 0001140361-26-016689-index-headers.html0001140361-26-016689
Document: 0001140361-26-016689-index.html0001140361-26-016689
Document: 0001140361-26-016689.txt0001140361-26-016689

US Market Status

Market Closed · Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026